April 28th 2025
Your daily dose of the clinical news you may have missed.
April 25th 2025
At current vaccination rates, measles could become endemic in the US again within 21 years; the threat extends to rubella, polio, and diphtheria, the study found.
April 17th 2025
The CDC advisory committee also endorsed GSK's pentavalent meningococcal vaccine.
April 15th 2025
Data from the EAGLE-1 study found gepotidacin to be noninferior to ceftriaxone plus azithromycin for treating uncomplicated urogenital gonorrhea.
April 9th 2025
AAAAI 2025: RSV vaccine and immunoprophylaxis uptake remained low in 2024 across infants, pregnant individuals, and older adults.
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 31, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Shingles Vaccination Significantly Reduced Dementia Risk in Large Retrospective Cohort Study
In persons who received both the HZV and Tdap vaccines, a significant 50% reduction in risk of dementia was seen, suggesting a nonspecific underlying association.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 27, 2022
PrEP for HIV Prevention: A Guideline Update Topline
The CDC update recommends that clinicians advise all sexually active patients about PrEP and includes a new section on prescribing injectable bimonthly cabotegravir.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 26, 2022
The End of the HIV Pandemic: Whatever Happened to 90-90-90 by 2020?
Get 90% of all HIV-infected persons diagnosed, get 90% of them on ART, and get 90% of those on ART “undetectable.” Are we there yet?
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 24, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 21, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 19, 2022
“Nocebo” Effect Accounted for Nearly Two-thirds of COVID-19 Vaccine Adverse Events in New Analysis
Findings highlight the importance of educating the public about the potential for nocebo responses to help reduce worries about COVID-19 vaccination.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 18, 2022
At-home STD Tests in California Must be Covered by Insurance, says New Law
California on Jan 1 became the first state to require insurance coverage for at-home testing for sexually transmitted infections; it isn't smooth sailing, yet.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 14, 2022
Seen in the ED: Positive Blood Culture
A man in his mid-60s presents after 1 month of intermittent fevers; recent blood cultures were positive for oral flora. Follow the ED course--can you make the diagnosis?
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 13, 2022
7 COVID-19 Home Test Kits Ranked by Usability
Seven at-home COVID-19 rapid tests, all available online or at retail, are ranked for dexterity required, instruction legibility, and other features you may need to parse for your patients.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 11, 2022
Non-COVID-19 Vaccines Could Help Reduce the Burden of Pandemic, Suggests New Research
New research suggests heterologous vaccine interventions with low efficacy can significantly reduce COVID-19 cases, hospitalizations, and deaths.
US Flu Activity for the Week Ended 1/1/2022
Click through top flu indicators tracked by the Centers for Disease Control and Prevention weekly US influenza surveillance report.
Shingles Vaccine Recap: A Shingrix Primer for Primary Care
Herpes zoster vaccination rates in the US have ticked up only minimally since FDA approval of Shingrix. Brush up on the basics of the vaccine and pass it on to your patients.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 10, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 7, 2022
Atopic Disease, Particularly Asthma, Linked to Decreased Risk of COVID-19 Infection in UK Adults
Adults with atopic disease and asthma had a 38% decreased risk of COVID-19 infection, according to a new UK study.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 5, 2022
AAP Recommends Routine HIV Screening for all Adolescents Starting at Age 15
The AAP updated its guidance to recommend routine HIV screening at least once in all adolescents aged ≥15 years and at-risk youth be rescreened annually.
New Study Suggests Obesity is Modifiable Risk Factor for Severe COVID-19 Infection
Among patients with obesity, prior weight loss achieved with bariatric surgery was associated with a 60% lower risk of severe COVID-19, suggests new research.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 4, 2022
J&J Booster Found 85% Effective Against Severe Disease During Peak Omicron Case Load
The J&J booster shot given to health care workers in South Africa between mid-Nov and mid-Dec 2021 was highly effective against Omicron infection.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 3, 2022